BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sanai FM, Abaalkhail F, Hasan F, Farooqi MH, Nahdi NA, Younossi ZM. Management of nonalcoholic fatty liver disease in the Middle East. World J Gastroenterol 2020; 26(25): 3528-3541 [PMID: 32742124 DOI: 10.3748/wjg.v26.i25.3528] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang B, Yang X, Tan X, Lu L, Fan W, Barbier-torres L, Steggerda J, Liu T, Yang H. Regulatory Networks, Management Approaches, and Emerging Treatments of Nonalcoholic Fatty Liver Disease. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-18. [DOI: 10.1155/2022/6799414] [Reference Citation Analysis]
2 Nguyen HH, Lee SS. Fluctuating hepatitis B viremia: Full of sound and fury, signifying nothing? Saudi J Gastroenterol 2022. [PMID: 35946260 DOI: 10.4103/sjg.sjg_307_22] [Reference Citation Analysis]
3 Anstee QM, Hallsworth K, Lynch N, Hauvespre A, Mansour E, Kozma S, Marino JP, Bottomley J, Piercy J, Higgins V. Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions. JHEP Rep 2022;4:100411. [PMID: 34977520 DOI: 10.1016/j.jhepr.2021.100411] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
4 Chen H, Zhan Y, Zhang J, Cheng S, Zhou Y, Chen L, Zeng Z. The global, regional, and national burden and trends of NAFLD in 204 countries and territories: an analysis from Global Burden of Disease 2019 (Preprint). JMIR Public Health and Surveillance 2021. [DOI: 10.2196/34809] [Reference Citation Analysis]
5 Kabarra K, Golabi P, Younossi ZM. Nonalcoholic steatohepatitis: global impact and clinical consequences. Endocr Connect 2021;10:R240-7. [PMID: 34486981 DOI: 10.1530/EC-21-0048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
6 Golabi P, Paik JM, AlQahtani S, Younossi Y, Tuncer G, Younossi ZM. Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019. J Hepatol 2021:S0168-8278(21)00358-5. [PMID: 34081959 DOI: 10.1016/j.jhep.2021.05.022] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 21.0] [Reference Citation Analysis]
7 Hashim MJ, Rizvi SS, Khan G. Hepatocellular Carcinoma in the United Arab Emirates. Liver Cancer in the Middle East 2021. [DOI: 10.1007/978-3-030-78737-0_6] [Reference Citation Analysis]